1OTrastuzumab emtansine (T-DM1) vs trastuzumab (H) in...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

1OTrastuzumab emtansine (T-DM1) vs trastuzumab (H) in Chinese patients (pts) with residual invasive disease after neoadjuvant chemotherapy for HER2-positive breast cancer (BC) in the phase III KATHERINE study

Huang, C, Yang, Y, Kwong, A, Chen, S-C, Tseng, L-M, Liu, M-C, Shen, K, Wang, S, Ng, T-Y, Feng, Y, Sun, G, Yan, I R, Shao, Z
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz416
Date:
November, 2019
File:
PDF, 102 KB
english, 2019
Conversion to is in progress
Conversion to is failed